Logo-jhp
J Herbmed Pharmacol. 2018;7(3): 193-199. doi: 10.15171/jhp.2018.31

Original Article

Therapeutic effect of Melissa officinalis in an amyloid-β rat model of Alzheimer’s disease

Siamak Beheshti 1 * ORCID, Bahareh Shahmoradi 1

Cited by CrossRef: 5

1- Navolokin N, Adushkina V, Zlatogorskaya D, Telnova V, Evsiukova A, Vodovozova E, Eroshova A, Dosadina E, Diduk S, Semyachkina-Glushkovskaya O. Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease. Pharmaceuticals. 2024;17(6):788 [Crossref]
2- Wang Y, Huang Y, Ma A, You J, Miao J, Li J. Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer’s Disease at the Early Stage. J Agric Food Chem. 2024;72(21):11854 [Crossref]
3- Sameni H, Vafaei A, Zarbakhsh S, Talebian A, Aldaghi M. Effects of Aminoguanidine on Apoptosis in the Hippocampus and Memory Disorder in a Rat Model of Alzheimer’s Disease. Middle East J Rehabil Health Stud. 2021;8(4) [Crossref]
4- Wang Z, Gao C, Zhang L, Sui R. RETRACTED: Hesperidin methylchalcone (HMC) hinders amyloid-β induced Alzheimer's disease by attenuating cholinesterase activity, macromolecular damages, oxidative stress and apoptosis via regulating NF-κB and Nrf2/HO-1 pathways. International Journal of Biological Macromolecules. 2023;233:123169 [Crossref]
5- Kumar S, Singh S, Rajput D, Sharma B, Chaturvedi K, Singh N, Saha S, Singh K, Mukherjee S. Pharmacological Approaches and Herbal Interventions for Alzheimer's Disease. NPJ. 2024;14(8) [Crossref]
6- Bordoloi S, Pathak K, Devi M, Saikia R, Das J, Kashyap V, Das D, Ahmad M, Abdel-Wahab B. Some promising medicinal plants used in Alzheimer’s disease: an ethnopharmacological perspective. Discov Appl Sci. 2024;6(5) [Crossref]
7- Calfio C, Gonzalez A, Singh S, Rojo L, Maccioni R. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease. JAD. 2020;77(1):33 [Crossref]